SCHEMBL1634458

SCHEMBL1634458

CC(C)(N)C(C)(C)C=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2154678 0.76 TDP1 (0.35)
SCHEMBL1013973 0.72
SCHEMBL3844855 0.72
SCHEMBL7744470 0.71
Hydrochloric Acid SCHEMBL5562938 0.69
Hydrochloric Acid SCHEMBL6637501 0.69
SCHEMBL2298640 0.69
SCHEMBL4828750 0.69
Hydrochloric Acid SCHEMBL5183654 0.67
SCHEMBL5992994 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12622932-B2 Immunomodulatory cells and uses thereof SINAI HEALTH SYSTEM (CA) 2026-05-12 US claimed
US-20220260583-A1 CHEMOPROTEOMIC PROFILING OF PROTEIN ELECTROPHILIC AND OXIDATIVE POST-TRANSLATIONAL MODIFICATIONS Zenagem, LLC 2022-08-18 US claimed
US-11226337-B2 Chemoproteomic profiling of protein electrophilic and oxidative post-translational modifications Zenagem, LLC (US) 2022-01-18 US claimed
EP-3465213-A1 METABALOMICS AND VIRAL DIAGNOSTICS SUITE Excision Biotherapeutics, Inc. (US) 2019-04-10 EP claimed
WO-2017205460-A1 METABALOMICS AND VIRAL DIAGNOSTICS SUITE EXCISION BIOTHERAPEUTICS, INC. (US) 2017-11-30 WO claimed
US-7718414-B2 Microorganism of Enterobacteriacae genus haboring genes associated with L-carnitine biosynthesis and method of producing L-carnitine using the microorganism CJ CHEILJEDANG CORP. (KR) 2010-05-18 US claimed
US-12622932-B2 Immunomodulatory cells and uses thereof SINAI HEALTH SYSTEM (CA) 2026-05-12 US disclosed
WO-2025038636-A1 ANTIVIRAL SUPPLEMENT FORMULATIONS FOR HERPESVIRUS INFECTIONS Vymedic, Inc. (US) 2025-02-20 WO disclosed
US-20250057865-A1 ANTIVIRAL SUPPLEMENT FORMULATIONS FOR HERPESVIRUS INFECTIONS Vymedic, Inc. 2025-02-20 US disclosed
US-20240123078-A1 COMPOUNDS AND METHODS FOR MODULATING IMMUNE-RELATED PROTEINS VIVIDION THERAPEUTICS, INC. 2024-04-18 US disclosed
US-20240075048-A1 ANTIVIRAL SUPPLEMENT FORMULATIONS VYMEDIC INC. 2024-03-07 US disclosed
US-11826377-B2 Antiviral supplement formulations VYMEDIC, LLC (US) 2023-11-28 US disclosed
US-20230101980-A1 METHOD, SYSTEM AND APPARATUS FOR SUBSTANCE IDENTIFICATION Trillitye PAULLIN (US) 2023-03-30 US disclosed
EP-1904620-A1 A MICROORGANISM OF ENTEROBACTERIACAE GENUS HABORING GENES ASSOCIATED WITH L-CARINTINE BIOSYNTHESIS AND METHOD OF PRODUCING L-CARNITINE USING THE MICROORGANISM CJ Cheiljedang Corp. (KR) 2008-04-02 EP disclosed
EP-1904632-A1 A MICROORGANISM OF ENTEROBACTERIACAE GENUS HABORING GENES ASSOCIATED WITH L-CARINTINE BIOSYNTHESIS AND METHOS OF PRODUCING L-CARNITINE USING THE MICROORGANISM CJ Corporation (KR) 2008-04-02 EP disclosed
WO-2007011087-A9 A MICROORGANISM OF ENTEROBACTERIACAE GENUS HABORING GENES ASSOCIATED WITH L-CARINTINE BIOSYNTHESIS AND METHOS OF PRODUCING L-CARNITINE USING THE MICROORGANISM CJ CORP (KR) 2007-06-07 WO disclosed
WO-2007011087-A1 A MICROORGANISM OF ENTEROBACTERIACAE GENUS HABORING GENES ASSOCIATED WITH L-CARINTINE BIOSYNTHESIS AND METHOS OF PRODUCING L-CARNITINE USING THE MICROORGANISM CJ CORPORATION (KR) 2007-01-25 WO disclosed
WO-2007007987-A1 A MICROORGANISM OF ENTEROBACTERIACAE GENUS HABORING GENES ASSOCIATED WITH L-CARINTINE BIOSYNTHESIS AND METHOD OF PRODUCING L-CARNITINE USING THE MICROORGANISM CJ CHEILJEDANG CORP. (KR) 2007-01-18 WO disclosed
US-20060035972-A1 Therapeutic compositions and uses CHEMGENES CORPORATION 2006-02-16 US disclosed
US-4515986-A FROM ISOBUTYRALDEHYDE, DIMETHYLAMINE AND FORMALDEHYDE AT ALKALINE PH RUHRCHEMIE AKTIENGESELLSCHAFT (DE) 1985-05-07 US disclosed